Legal
503A Compounding Disclosure
Effective To be set · Last updated To be set
Avellum Health
Avellum Health's 503A compounding disclosure is being prepared by counsel. This page is a placeholder while that work is in progress.
What this page will cover
Avellum protocols are compounded by a licensed 503A pharmacy partner. When the final disclosure is published, it will describe the difference between FDA-approved manufactured drugs and compounded preparations, how the pharmacy operates under Section 503A of the Federal Food, Drug, and Cosmetic Act, the role of the prescribing provider, and the patient acknowledgement that applies at the time of order.
Questions
Reach out to support@avellumhealth.com with any questions before the final disclosure is posted.